Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Spignoli

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|July 31, 1986
Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesiaG Spignoli, G Pepeu
Clinical Neuropharmacology|January 1, 1986
Effect of oxiracetam on cognition and brain cholinergic mechanismsG Pepeu, G Spignoli
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Nootropic drugs and brain cholinergic mechanismsG Pepeu, G Spignoli
La Clinica Terapeutica|April 15, 1986
[DEAE-dextran in hyperlipoproteinemia and obesity]G Spignoli, L Principe
Advances in Neurology|January 1, 1990
Neurochemical actions of "nootropic drugs"G Pepeu, G Spignoli
Drugs Under Experimental and Clinical Research|January 1, 1990
Investigations on the binding properties of the nootropic agent pyroglutamic acidD Barone, G Spignoli
Pharmacology, Biochemistry, and Behavior|July 1, 1987
Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholineG Spignoli, G Pepeu
Psychopharmacology|January 1, 1990
Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerateF Paoli, G Spignoli, G Pepeu
European Journal of Pharmacology|January 27, 1984
A1 and A2 adenosine receptors modulate acetylcholine release from brain slicesG Spignoli, F Pedata, G Pepeu
British Journal of Pharmacology|September 1, 1984
Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slicesF Pedata, G Pepeu, G Spignoli
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|July 31, 1986
Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesiaG Spignoli, G Pepeu
Clinical Neuropharmacology|January 1, 1986
Effect of oxiracetam on cognition and brain cholinergic mechanismsG Pepeu, G Spignoli
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Nootropic drugs and brain cholinergic mechanismsG Pepeu, G Spignoli
La Clinica Terapeutica|April 15, 1986
[DEAE-dextran in hyperlipoproteinemia and obesity]G Spignoli, L Principe
Advances in Neurology|January 1, 1990
Neurochemical actions of "nootropic drugs"G Pepeu, G Spignoli
Drugs Under Experimental and Clinical Research|January 1, 1990
Investigations on the binding properties of the nootropic agent pyroglutamic acidD Barone, G Spignoli
Pharmacology, Biochemistry, and Behavior|July 1, 1987
Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholineG Spignoli, G Pepeu
Psychopharmacology|January 1, 1990
Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerateF Paoli, G Spignoli, G Pepeu
European Journal of Pharmacology|January 27, 1984
A1 and A2 adenosine receptors modulate acetylcholine release from brain slicesG Spignoli, F Pedata, G Pepeu
British Journal of Pharmacology|September 1, 1984
Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slicesF Pedata, G Pepeu, G Spignoli
Pageof 3